mRNA Vaccines for COVID-19
Recently, a rush of interim analyses from pharmaceutical companies Moderna and Pfizer/BioNTech has spurred optimism that a novel type of vaccine made from messenger RNA, known as mRNA, can offer high levels of protection by preventing COVID-19 among people who are vaccinated.
- Moderna’s new mRNA vaccine is almost 94.5% effective in large-scale trials. Similarly, Pfizer’s vaccine has also shown an efficacy of around 95%.
mRNA Vaccine Function
- mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, a mRNA vaccine teaches our cells how to make a protein or even just a portion ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 AI@Work
- 2 In-Orbit Snooping
- 3 SaaSpocalypse
- 4 WHO Prequalifies Novel Oral Polio Vaccine Type 2 (nOPV2)
- 5 VoicERA on BHASHINI National Infrastructure
- 6 Indigenous Td Vaccine Launched
- 7 INCOIS Launches Three Ocean Information Services
- 8 Solid Fuel Ducted Ramjet (SFDR) Technology
- 9 Agni-III Missile Test: India Validates Strategic Deterrence Capability
- 10 L&T Wins Contract to Build India’s LIGO Observatory in Maharashtra
